Early Phase 1 Multiple Sclerosis (MS) Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

Multiple Sclerosis (MS) - Relapsing-remitting

Georgia State University25 enrolled2 locationsNCT06629428

Recruiting

Early Phase 1

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more

Daishi Tian36 enrolled1 locationNCT07337785